{"groups":[{"description":"Velcade 1.0 mg/m\\^2 Velcade 1.3 mg/m\\^2 D1,4, 8, 11 (x 6 cycles, then 1.0 mg/m\\^2 (for cycles 7-12) Thalidomide 100 mg D1-28 Dexamethasone 20 mg D1-4 and 8-11","id":"FG000","title":"Velcade, Thalidomide, and Dexamethasone"},{"description":"VMD:\n\nVelcade 1.3 mg/m\\^2 D1, 4, 7, 10 (x6 mo, then 1.0 mg/m\\^2) Melphalan 4 (6, 8, 10) mg/m\\^2 D1, 4, 7, 10 dose escalation Dexamethasone 20 mg 1-4 and 7-10","id":"FG001","title":"VMD With Melphalan Dose Escalation"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"2"}],"type":"study stopped"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"Death"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"2"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"2"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}